Quick Comparison

Citicoline (CDP-Choline)Gotu Kola
Half-Life56-71 hours (sustained release characteristics)2-4 hours (asiaticoside, madecassoside)
Typical DosageStandard: 250-500 mg daily. Clinical studies use 500-2000 mg daily. Take in the morning — mildly stimulating. Cognizin is the most studied form. Can be split into 2 doses. Often combined with racetams to provide the choline needed for enhanced acetylcholine turnover.Standard: 500-1000 mg standardized extract daily (triterpenes: asiaticoside, madecassoside). Traditional dose: 1-2 grams dried herb as tea. ECa 233 is a well-studied standardized extract. Can be taken morning or evening — mild enough for bedtime use.
AdministrationOral (capsules, powder). Cognizin branded form is most studied. Take in the morning.Oral (capsules, extract, tea, tincture). ECa 233 standardized extract for consistent dosing.
Research Papers10 papers9 papers
Categories

Mechanism of Action

Citicoline (CDP-Choline)

Citicoline (CDP-choline) is hydrolyzed in the gut by alkaline phosphatase to choline and cytidine-5'-monophosphate, which are absorbed separately and reassembled in the brain via the Kennedy pathway. Choline feeds two critical pathways: (1) Acetylcholine synthesis via choline acetyltransferase (ChAT) — the primary memory and learning neurotransmitter acting at muscarinic and nicotinic receptors. (2) Phosphatidylcholine synthesis via CTP:phosphocholine cytidylyltransferase — the structural component of neuronal membranes and synaptic vesicles. Cytidine is dephosphorylated to uridine, converted to UTP, and supports RNA synthesis and CDP-choline formation for synapse formation. Citicoline also activates SIRT1 (possibly via NAD+ modulation) and increases brain norepinephrine and dopamine (mechanism unclear — may enhance synthesis or release). It is the only choline source providing both cholinergic and membrane-building support in one molecule.

Gotu Kola

Triterpene saponins (asiaticoside, madecassoside, asiatic acid, madecassic acid) are the primary bioactives. They increase BDNF expression in the hippocampus via CREB and ERK/MAPK pathways, promoting neuroplasticity, synaptogenesis, and memory formation. They enhance collagen type I synthesis through stimulation of fibroblasts and improve microcirculation via VEGF and angiopoietin modulation. Anxiolytic effects occur through positive allosteric modulation of GABA-A receptors (possibly at the benzodiazepine or neurosteroid site) and reduction of acoustic startle response (amygdala modulation). Gotu kola inhibits acetylcholinesterase (AChE), mildly increasing synaptic acetylcholine. Anti-inflammatory effects come from NF-kB inhibition (IkB stabilization) and TNF-alpha suppression. Asiatic acid may also activate PPAR-gamma.

Risks & Safety

Citicoline (CDP-Choline)

Common

Headache (especially with racetams — indicates too much cholinergic stimulation), nausea, diarrhea.

Serious

None documented at standard doses.

Rare

Insomnia, blurred vision.

Gotu Kola

Common

Very well-tolerated. Mild GI upset, drowsiness.

Serious

Rare hepatotoxicity reported — avoid with liver disease and limit use to 6-week cycles.

Rare

Headache, dizziness, skin sensitivity to sunlight.

Full Profiles